ARCH Venture Fund X Overage, L.P. (CIK 1757017) reported 4 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-07-06). Recent activity: Buy BOLD (16,000 shares), Sell BOLD (16,000 shares), Buy NMRA (1.9M shares), Buy PRME (3.0M shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-06 | Boundless Bio, Inc. (BOLD) | Insider | Buy | 16,000 | $16,480 |
| 2026-07-06 | Boundless Bio, Inc. (BOLD) | Insider | Sell | 16,000 | $39,840 |
| 2025-10-29 | Neumora Therapeutics, Inc. (NMRA) | Insider | Buy | 1.9M | $5.0M |
| 2025-08-01 | Prime Medicine, Inc. (PRME) | Insider | Buy | 3.0M | $10.0M |
Source: SEC Form 4 filings · as of 2026-07-06